0001104659-22-001617.txt : 20220105 0001104659-22-001617.hdr.sgml : 20220105 20220105185008 ACCESSION NUMBER: 0001104659-22-001617 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220105 FILED AS OF DATE: 20220105 DATE AS OF CHANGE: 20220105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Beebe Katherine CENTRAL INDEX KEY: 0001768867 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13341 FILM NUMBER: 22512966 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD, SUITE 505 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000910267 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502444990 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 4 1 tm221868-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-01-05 0 0000910267 TITAN PHARMACEUTICALS INC TTNP 0001768867 Beebe Katherine 400 OYSTER POINT BLVD., SUITE 505 SO. SAN FRANCISCO CA 94080 1 1 0 0 President and COO Option to Purchase Common Stock 1.18 2022-01-05 4 A 0 55000 0 A 2032-01-05 Common Stock 55000 55000 D The options vest as to 27,500 shares on July 5, 2022 with the balance to vest in equal monthly installments over the 18 months thereafter. /S/ Kate Beebe Devarney 2022-01-05